Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

UK7

INHERITED CANCER GENETICS

  • First published: 09 July 2026
  • Last modified: 09 July 2026
  • Version: 1
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
ocds-h6vhtk-06bcee
Published by:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Authority ID:
AA0221
Publication date:
09 July 2026
Deadline date:
-
Notice type:
UK7
Has documents:
Yes
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Cardiff and Vale University Health Board intends to award a contract for the provision of outsourced inherited cancer genetic testing services to a single supplier.This service is critical to supporting the All Wales Medical Genomics Service (AWMGS), ensuring continued access to timely and accurate diagnostic testing across Wales. Ongoing capacity constraints within in-house laboratory services, combined with sustained clinical demand, require the continuation of outsourced provision to maintain turnaround times and support patient care pathways.The selected supplier is already embedded within the service and has demonstrated the capability and capacity to deliver the required testing to the necessary quality standards. Maintaining this arrangement ensures continuity of service and avoids disruption to established clinical pathways.Introducing an alternative supplier at this stage would present significant operational and clinical risks, including delays to patient diagnosis, disruption to workflows, and additional onboarding and validation requirements.Awarding to a sole supplier is therefore considered necessary to ensure continuity of critical services, protect patient safety, and support ongoing service delivery.

Full notice text

Scope

Procurement reference

CAV-DIR (26-27) 49

Procurement description

Cardiff and Vale University Health Board intends to award a contract for the provision of outsourced inherited cancer genetic testing services to a single supplier.This service is critical to supporting the All Wales Medical Genomics Service (AWMGS), ensuring continued access to timely and accurate diagnostic testing across Wales. Ongoing capacity constraints within in-house laboratory services, combined with sustained clinical demand, require the continuation of outsourced provision to maintain turnaround times and support patient care pathways.The selected supplier is already embedded within the service and has demonstrated the capability and capacity to deliver the required testing to the necessary quality standards. Maintaining this arrangement ensures continuity of service and avoids disruption to established clinical pathways.Introducing an alternative supplier at this stage would present significant operational and clinical risks, including delays to patient diagnosis, disruption to workflows, and additional onboarding and validation requirements.Awarding to a sole supplier is therefore considered necessary to ensure continuity of critical services, protect patient safety, and support ongoing service delivery.

Contracting authority

Cardiff and Vale University Health Board

Identification register:

  • GB-PPON

Address 1: Woodland House

Town/City: Cardiff

Postcode: CF14 4HH

Country: United Kingdom

Website: http://nwssp.nhs.wales/ourservices/procurement-services/

Public Procurement Organisation Number: PPPR-7969-BTJG

Contact name: Nicola Williams

Email: Nicola.williams33@wales.nhs.com

Telephone: +442921500649

Organisation type: Public authority - sub-central government

Devolved regulations that apply: Wales

Supplier

Informed Genetics

Identification register:

  • GB-PPON

Address 1: Unit 5, quinton business park,11 Ridgeway

Town/City: Birmingham

Postcode: B32 1AF

Country: United Kingdom

Public Procurement Organisation Number: PZXY-1897-VDDJ

Email: Izzie.Coakley@nonacus.com

Type:

  • Large

Procedure

Procedure type

Direct award

Description of how these justifications apply

Single supplier – technical reasons The requirement relates to a highly specialised clinical service for inherited cancer genetic testing, which requires specific technical capability, accredited laboratory processes, and integration with existing clinical pathways. The identified supplier has the necessary infrastructure, validated methodologies, and established interfaces with the All Wales Medical Genomics Service (AWMGS), enabling continuity of testing, reporting, and data management. These technical requirements cannot be readily replicated by alternative suppliers within the required timeframe without significant disruption. Furthermore, the supplier’s ability to deliver within existing turnaround times, manage current demand, and support backlog recovery is dependent on proprietary systems, validated workflows, and specialist expertise. Transitioning to an alternative supplier would necessitate duplication of validation processes, interface development, and clinical assurance activity, introducing unacceptable operational and clinical risk. Single supplier – unique work of art or performance (proprietary justification) The service provision is considered proprietary in nature due to the supplier’s established integration within the current service model, including embedded processes, reporting mechanisms, and clinical pathways specific to AWMGS requirements. The supplier is already delivering testing services aligned to the Health Board’s specifications, with proven performance in managing complex and high-volume diagnostic workloads. Their service includes unique elements such as established data flows, validated testing protocols, and familiarity with Welsh clinical pathways, which collectively form a bespoke service offering that is not readily transferable. Any change in supplier would require significant revalidation of testing processes, redevelopment of interfaces, and onboarding of clinical pathways, which would disrupt service delivery and delay patient diagnosis. This establishes the supplier as the only provider capable of delivering the required service without interruption, therefore justifying a sole supplier award on the basis of proprietary service delivery.

Direct award justification

Single suppliers intellectual property exclusive rights

Contract

INHERITED CANCER GENETICS

ID: 1

Is the total value above threshold?

Above threshold

Date the contract will be signed (estimated)

08 July 2026, 00:00AM

Contract dates (estimated)

01 January 2027, 00:00AM to 31 December 2027, 23:59PM

Documents

ID

A-18951

Document type

Lots

Divided into 1 lots

Lot number: 1 Status: Complete

Documents

ID

conflictOfInterest

Document type

Conflict of interest

Description

Not published

Coding

Commodity categories

ID Title Parent category
85148000 Medical analysis services Miscellaneous health services

Delivery locations

ID Description
1022 Cardiff and Vale of Glamorgan

Document family

Notice details
Publication date:
25 June 2026
Deadline date:
Notice type:
UK5
Version:
1
Authority name:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Publication date:
25 June 2026
Deadline date:
Notice type:
UK6
Version:
1
Authority name:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Publication date:
09 July 2026
Deadline date:
Notice type:
UK7
Version:
1
Authority name:
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

About the buyer

Main contact:
n/a
Admin contact:
n/a
Technical contact:
n/a
Other contact:
n/a

Further information

Date Details

Additional documents

The following additional documents have been attached to this notice. To obtain these documents please select the individual file names below.

Current documents

pdf
pdf273.26 KB
This file may not be accessible.
pdf
pdf273.26 KB
This file may not be accessible.

Replaced documents

There are no previous versions of these documents.


0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.